Thibault Mésplède - Concepedia

Author

Thibault Mésplède

Also Known As

; Plummer, Kaitlin Anstett, Mesplede, T., T Mesplede, T Mesplède, T. Mesplede, T. Mesplède, Thibault Mesplede, Thibault Mesplède, Thibault Mesplède

136

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

McGill University Jewish General Hospital Université Paris Cité McGill University Health Centre Université de Montréal

About

Thibault Mésplède is an author at McGill University specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	18	447
2	Natural Sciences	2	2	36
3	Biochemistry	2	2	36
4	Engineering	1	1	67
5	Health Sciences	1	1	14

Thibault Mésplède

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir Peter K. Quashie, Thibault Mésplède, Ying-Shan Han, Journal of Virology	2011	231
The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation Peyman Nakhaei, Thibault Mésplède, Mayra Solis, PLoS Pathogens	2009	168
Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure Thibault Mésplède, Peter K. Quashie, Nathan Osman, Retrovirology	2013	130
p53 Degradation Activity, Expression, and Subcellular Localization of E6 Proteins from 29 Human Papillomavirus Genotypes Thibault Mésplède, David Gagnon, Fanny Bergeron-Labrecque, Journal of Virology	2011	91
The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness Melissa Wares, Thibault Mésplède, Peter K. Quashie, Retrovirology	2014	80
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy Ingeborg E A Wijting, Cynthia Lungu, Bart Rijnders, The Journal of Infectious Diseases	2018	78
Differential Effects of the G118R, H51Y, and E138K Resistance Substitutions in Different Subtypes of HIV Integrase Peter K. Quashie, M Oliviera, Tamar Veres, Journal of Virology	2015	75
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors Bluma Brenner, Réjean Thomas, José Luís Blanco, Journal of Antimicrobial Chemotherapy	2016	71
Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase Peter K. Quashie, Thibault Mésplède, Ying-Shan Han, Antimicrobial Agents and Chemotherapy Hiv-1 IntegraseEngineeringBiochemical AnalysisHiv IntegraseGlycobiology	2013	67
Transcriptional re‐programming of primary macrophages reveals distinct apoptotic and anti‐tumoral functions of IRF‐3 and IRF‐7 Delphine Goubau, Raphaëlle Romieu‐Mourez, Mayra Solis, European Journal of Immunology ApoptosisImmunologyCell DeathPathologyImmunologic Mechanism	2009	64

Page 1